---
title: "BACHLEDA MARK — Ownership Dossier"
canonical: https://whiteintel.dev/entity/9dc6788a-eba9-53b0-9167-0adeee9ffcaa
json: https://whiteintel.dev/api/public/dossier/9dc6788a-eba9-53b0-9167-0adeee9ffcaa
identifier: sec:0001887762
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BACHLEDA MARK

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001887762`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/9dc6788a-eba9-53b0-9167-0adeee9ffcaa  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9dc6788a-eba9-53b0-9167-0adeee9ffcaa  

## Ownership & control

### Holdings / subsidiaries

- **Lyell Immunopharma, Inc.** (director) — https://whiteintel.dev/entity/eeb1283f-805a-5e39-98c5-0756afaf7715
- **Galera Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/d29cee4e-6c7d-5845-98d3-81aef0672b42

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BACHLEDA MARK**. Human view: https://whiteintel.dev/entity/9dc6788a-eba9-53b0-9167-0adeee9ffcaa · Structured JSON: https://whiteintel.dev/api/public/dossier/9dc6788a-eba9-53b0-9167-0adeee9ffcaa._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._